W
Wendy Matoz
Researcher at University of Zagreb
Publications - 3
Citations - 149
Wendy Matoz is an academic researcher from University of Zagreb. The author has contributed to research in topics: Free radical scavenger & Reserpine. The author has an hindex of 2, co-authored 3 publications receiving 140 citations.
Papers
More filters
Journal ArticleDOI
A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC
Predrag Sikiric,Marijan Petek,Rudolf Rucman,Sven Seiwerth,Zeljko Grabarevic,Ivo Rotkvić,Branko Turkovic,Vjekoslav Jagić,Boris Mildner,Marko Duvnjak,Nada Lang,Z. Danilović,A. Cviko,M. Kolega,Ahmet Sallmani,S. Djačić,Miljenko Bura,Tomislav Brkić,Marko Banić,Milan Dodig,V. Corić,Velimir N. Šimičević,Marija Veljača,Damir Erceg,Damir Ježek,L.J. Simunić-Banek,N. Skroza,Krešimir Bulić,Gojko Buljat,Miroslav Hanževački,V. Orihovac,Dražen Lučinger,Josip Čulig,Jadranka Separovic,Anton Marovic,Stjepan Mise,Ernest Suchanek,Wendy Matoz,Darko Perović,Miroslav Gjurašin,S. Mikulandra,K. Derniković,V. Cuk,I. Karakas +43 more
TL;DR: BPC, as a possible endogenous free radical scavenger and organoprotection mediator, could be a useful prototype of a new class of drugs, organoprotsective agents.
Journal ArticleDOI
A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson's disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydrophyridine.
Predrag Sikiric,Anton Marovic,Wendy Matoz,Tomislav Anic,Gojko Buljat,Darko Mikus,Dinko Stančić-Rokotov,Jadranka Separovic,Sven Seiwerth,Zeljko Grabarevic,Rudolf Rucman,Marijan Petek,Tomislav Ziger,Božidar Šebečić,Ivan Zoricic,Branko Turkovic,Gorana Aralica,Darko Perović,Božidar Duplancic,Martina Lovrić-Benčić,Ivo Rotkvić,Stjepan Mise,Vjekoslav Jagić,Vladimir Hahn +23 more
TL;DR: Giving in either regimen, pentadecapeptide BPC 157 strongly attenuated the stomach lesions in mice that otherwise consistently appeared in mice treated with the parkinsogenic neurotoxin MPTP, leading to almost complete abolition of otherwise regularly lethal course of MPTP treatment in controls.
A new gastric juice peptide, BPC - an overview of stomach (stress) organoprotection hypothesis and BPC befitial effects
Predrag Sikiric,Marijan Petek,Sven Seiwerth,Grabarević, Željko, Rotkvić, Ivo,Branko Turkovic,Vjekoslav Jagić,Boris Mildner,Marko Duvnjak,Nada Lang,Žarko Danilović,A. Cviko,Csaba Dohoczky,M. Kolega,Ahmet Sallmani,Sanja Đačić,Miljenko Bura,Tomislav Brkić,Marko Banić,Milan Dodig,V. Corić,Velimir N. Šimičević,Marija Veljača,Damir Erceg,Damir Ježek,Lj. Šimunić-Banek,N. Skroza,Krešimir Bulić,M. Hanzevacki,Dražen Lučinger,Josip Čulig,Jadranka Separovic,Anton Marovic,Stjepan Mise,Ernest Suchanek,Wendy Matoz,Daniela Perović,Miroslav Gjurašin,Simon. Mikulandra,K. Derniković,Višeslav Ćuk,Ivan Karakaš +40 more
TL;DR: It seems that BPC treatment does not share any of the so far known limitations for "conventional organoprotectors", and whether BPC, as a likely endogenous free radical scavenger and Organoprotection mediator, would be a useful prototype of a new class of drugs, organoprotsective agents, remains to be seen.